BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 32953738)

  • 21. [Prognostic factors of lymph node-negative metastasis gastric cancer].
    Sun D; Xu H; Huang J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):190-194. PubMed ID: 28226354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of the risk factor of insufficient examined lymph nodes in stage II colon cancer from the perspective of stage migration: A retrospective study combined with external validation.
    Zhang C; Zhao S; Wang X
    Int J Surg; 2022 May; 101():106628. PubMed ID: 35447364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and validation of a clinical cure marker based on negative lymph nodes for gastric cancer after gastrectomy.
    Xie J; Zhang Y; He M; Liu X; Dong J; Wang P; Pang Y
    Front Surg; 2023; 10():1016252. PubMed ID: 37228762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relationship between the number of examined lymph nodes and the efficacy of chemotherapy for gastric cancer.
    Gu L; Chen B; Shen Z; Khadaroo PA; Wang X; Zhu H; Pan J; Zhong X; Mao F; Chen P
    Surg Today; 2020 Jun; 50(6):585-596. PubMed ID: 31811459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of examined lymph node count on prognosis in patients with lymph node-negative pancreatic body/tail ductal adenocarcinoma.
    Li YF; Xiang YC; Zhang QQ; Wang WL
    J Gastrointest Oncol; 2020 Aug; 11(4):644-653. PubMed ID: 32953148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of the Extent of Lymph Node Dissection on Precise Staging and Survival in Clinical I-II Pure-Solid Lung Cancer Undergoing Lobectomy.
    Chen D; Mao Y; Wen J; Shu J; Ye F; She Y; Ding Q; Shi L; Xue T; Fan M; Chen Y; Chen C
    J Natl Compr Canc Netw; 2021 Apr; 19(4):393-402. PubMed ID: 33508774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The appropriate number of ELNs for lymph node negative breast cancer patients underwent MRM: a population-based study.
    Chi H; Zhang C; Wang H; Wang Z
    Oncotarget; 2017 Sep; 8(39):65668-65676. PubMed ID: 29029462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of examined lymph node count for oesophageal squamous cell carcinoma in patients who underwent left transthoracic oesophagectomy.
    Zheng YZ; Li XQ; Wang JY; Yang H; Wen J; Zhai WY; Yuan LX; Fu SS; Liao HY; Fu JH
    Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1956-1962. PubMed ID: 32439262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymph node ratio, but not the total number of examined lymph nodes or lymph node metastasis, is a predictor of overall survival for pancreatic neuroendocrine neoplasms after surgical resection.
    Liu P; Zhang X; Shang Y; Lu L; Cao F; Sun M; Tang Z; Vollmar B; Gong P
    Oncotarget; 2017 Oct; 8(51):89245-89255. PubMed ID: 29179516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insufficient examined lymph node count underestimates staging in pN3a patients after curative gastrectomy: a multicenter study with external validation.
    Dong Y; Qiu Y; Deng J; Wang W; Sun Z; Wang Z; Zhou Z; Xu H; Liang H
    J Cancer Res Clin Oncol; 2020 Feb; 146(2):515-528. PubMed ID: 31813005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Numbers and Stations: Impact of Examined Lymph Node on Precise Staging and Survival of Radiologically Pure-Solid NSCLC: A Multi-Institutional Study.
    Chen D; Mao Y; Wen J; Shu J; Ye F; She Y; Ding Q; Shi L; Xue T; Fan M; Chen Y; Chen C
    JTO Clin Res Rep; 2020 Sep; 1(3):100035. PubMed ID: 34589935
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Value of N1 Lymph Node Examination in the Prognosis of Patients With pT1-3N0M0 Non-Small Cell Lung Cancer.
    Wang G; Wu X; Sun X; Li T; Xu M; Xu L; Xie M
    Front Oncol; 2020; 10():603378. PubMed ID: 33384960
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of Omission of Intrapulmonary Lymph Node Retrieval on Outcome Evaluation of Lung Cancer Patients Without Lymph Node Metastasis: A Propensity Score Matching Analysis.
    Wang X; Yan S; Lv C; Wang Y; Wang J; Li S; Zhang L; Yang Y; Wu N
    Clin Lung Cancer; 2017 Nov; 18(6):e411-e416. PubMed ID: 28576593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimal examined lymph node count in node-negative colon cancer should be determined.
    Feng H; Lyu Z; Liang W; Cai G; Deng Z; Jiang M; Wu D; Li Y
    Future Oncol; 2021 Oct; 17(29):3865-3872. PubMed ID: 34287061
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The outcome of young vs. old gastric cancer patients following gastrectomy: a propensity score matching analysis.
    Cheng YX; Tao W; Liu XY; Yuan C; Zhang B; Zhang W; Peng D
    BMC Surg; 2021 Nov; 21(1):399. PubMed ID: 34798854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alpha-fetoprotein is a significant prognostic factor for gastric cancer: Results from a propensity score matching analysis after curative resection.
    Reim D; Choi YS; Yoon HM; Park B; Eom BW; Kook MC; Ryu KW; Choi IJ; Joo J; Kim YW
    Eur J Surg Oncol; 2017 Aug; 43(8):1542-1549. PubMed ID: 28511775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determining the optimal number of examined lymph nodes for accurate staging of pancreatic cancer: An analysis using the nodal staging score model.
    Hua J; Zhang B; Xu J; Liu J; Ni Q; He J; Zheng L; Yu X; Shi S
    Eur J Surg Oncol; 2019 Jun; 45(6):1069-1076. PubMed ID: 30685327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modified American Joint Committee on Cancer Tumor-Node-Metastasis Staging System Based on the Node Ratio Can Further Improve the Capacity of Prognosis Assessment for Gastric Cancer Patients.
    Yang ZL; Zhu MH; Han XJ; Liu QW; Long JH; Wang CX
    Front Oncol; 2019; 9():329. PubMed ID: 31131256
    [No Abstract]   [Full Text] [Related]  

  • 39. Different survival outcomes after curative R0-resection for Eastern Asian and European gastric cancer: Results from a propensity score matched analysis comparing a Korean and a German specialized center.
    Kim YW; Joo J; Yoon HM; Eom BW; Ryu KW; Choi IJ; Kook MC; Schuhmacher C; Siewert JR; Reim D
    Medicine (Baltimore); 2016 Jul; 95(28):e4261. PubMed ID: 27428238
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of capecitabine and oxaliplatin versus S-1 as adjuvant chemotherapy in gastric cancer after D2 lymph node dissection according to lymph node ratio and N stage.
    Shin K; Park SJ; Lee J; Park CH; Song KY; Lee HH; Seo HS; Jung YJ; Park JM; Lee SH; Roh SY; Kim IH
    BMC Cancer; 2019 Dec; 19(1):1232. PubMed ID: 31852475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.